المصدر: A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05359133Test

المؤلفون: Celerion

المصدر: A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04083833Test

المصدر: A Multicentre , Randomized, Double-blind, Placebo-controlled, Parallel-design Trial of the Efficacy and Safety of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Inadequately Controlled Cancer-related Pain

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00725114Test

المصدر: A Multicentre, Open-label, Long-term Efficacy and Safety Continuation Study of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Cancer-related Pain

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00726011Test

المصدر: COMPARISON OF THE PHARMACOKINETICS AND SAFETY OF LIQUID (30 µg) AND LYOPHILIZED TETRODOTOXIN (15 µg AND 30 µg) FOLLOWING SINGLE AND TWICE DAILY SUBCUTANEOUS DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS-DETERMINATIONS IN BLOOD AND URINE

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01527734Test

Other URLs: http://www.wextech.caTest/

المؤلفون: Premier Research Group plc

المصدر: A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Phase II Multicenter Study of Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01655823Test